Blockchain Registration Transaction Record

Redcare Pharmacy Raises 2026 Guidance on Strong Rx Momentum

Redcare Pharmacy raises FY2026 revenue guidance again, driven by strong Rx momentum in Germany. Rx revenue now expected at EUR 730-760M, total growth 16-18%.

This news matters because it underscores the accelerating shift toward digital healthcare in Europe. Redcare Pharmacy's upward revision—its second this year—signals robust demand for online pharmacy services, particularly for prescription medications in Germany. The 51% year-on-year growth in Rx revenue in September, despite a tough comparison, demonstrates that customers are increasingly embracing e-prescriptions and digital pharmacy solutions. The rising eRx NPS score of 80 further indicates high satisfaction, which could drive sustained loyalty and market share gains. For investors, the raised guidance suggests stronger-than-expected financial performance, potentially boosting confidence in the company's growth trajectory. Moreover, as the leading online pharmacy in Europe with over 14 million active customers, Redcare's success highlights the broader trend of healthcare digitalization, which could pressure traditional brick-and-mortar pharmacies to innovate. Ultimately, this development benefits patients by expanding access to convenient, safe, and comprehensive pharmaceutical services.